Chunling Liu

Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study

Yuankai Shi, Gongyan Chen, Xiang Wang et al. · The Lancet Respiratory Medicine · 2022 · 230 citations

Medicine, Oncology, Pharmacology +13

MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer

Zhenwei Shi, Xiaomei Huang, Ziliang Cheng et al. · Radiology · 2023 · 225 citations · Full text

Medicine, Oncology, Radiology +17

Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: Comparison with conventional DWI

Chunling Liu, Changhong Liang, Zaiyi Liu et al. · European Journal of Radiology · 2013 · 201 citations · Full text

Medicine, Radiology, Biomedical Imaging +12

Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast‐enhanced MRI

Chunling Liu, Jie Ding, Karl Spuhler et al. · Journal of Magnetic Resonance Imaging · 2018 · 191 citations

Medicine, Oncology, Radiology +17

Intravoxel incoherent motion MR imaging for breast lesions: comparison and correlation with pharmacokinetic evaluation from dynamic contrast-enhanced MR imaging

Chunling Liu, Kun Wang, Queenie Chan et al. · European Radiology · 2016 · 89 citations

Medicine, Pharmacokinetics, Radiology +15